|
WO2007103162A2
|
|
Structure based drug design of steroidogenesis inhibitors
|
|
CN101227911A
|
|
Use of spirostenols to treat mitochondrial disorders
|
|
EP1755605A2
|
|
Use of (4-alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease
|
|
CN101001628A
|
|
Anti-HIV quinuclidine compounds
|
|
CN1960631A
|
|
Benzamide and benzoate anti-HIV compounds
|
|
US2005085464A1
|
|
Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human
|
|
EP1628649A2
|
|
Neuroprotective benzoate and benzamide compounds
|
|
CA2518407A1
|
|
Animal model simulating neurologic disease
|
|
EP1496913A2
|
|
Neuroprotective spirostenol pharmaceutical compositions
|
